Inventor · disambiguated record
Lei Jin
Also filed as: JIN LEI
39 granted patents·26 pending applications·678 citations·filing 2004–2024
98Inventor score
Files withEPIZYME INC44CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD8DAIAMED2UNIV CONNECTICUT2YOU CHAO2
Top patents by PatentIndex Score
65 records- 0199US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0299US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0398US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 0498US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 0598US9346802B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·32 claims
- 0698US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 0798US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 0897US10118931B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Nov 6, 2018·19 cites·4 claims
- 0997US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 1096US9856267B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jan 2, 2018·14 cites·4 claims
- 1196US9732041B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 15, 2017·17 cites·9 claims
- 1296US9388173B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 12, 2016·32 cites·23 claims
- 1396US9346761B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·36 claims
- 1496US9266836B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 23, 2016·35 cites·28 claims
- 1595US9777008B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Oct 3, 2017·16 cites·22 claims
- 1695US9765068B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Sep 19, 2017·14 cites·27 claims
- 1794US10391089B2PRMT5 inhibitors and uses therofEPIZYME INC·Filed 2017·Granted Aug 27, 2019·5 cites·19 claims
- 1894US10307413B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jun 4, 2019·5 cites·39 claims
- 1993US10112968B2Inhibitors of protein methyltransferase DOT1L and methods of use thereofEPIZYME INC·Filed 2016·Granted Oct 30, 2018·5 cites·14 claims
- 2093US9908887B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 6, 2018·14 cites·18 claims
- 2193US9745291B2PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2013·Granted Aug 29, 2017·14 cites·13 claims
- 2292US9776972B2Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Oct 3, 2017·14 cites·31 claims
- 2391US7767770B2Process for the oxidative dehydrogenation of ethaneROHM & HAAS·Filed 2009·Granted Aug 3, 2010·10 cites·10 claims
- 2491US7217794B2Compounds and methods for treatment of thrombosisDAIAMED INC·Filed 2004·Granted May 15, 2007·91 cites·6 claims
- 2587US7501404B2Substituted azetidinonesDAIMED·Filed 2006·Granted Mar 10, 2009·21 cites·17 claims
- 2686US10980794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Granted Apr 20, 2021·1 cites·20 claims
- 2784US9738651B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 22, 2017·4 cites·18 claims
- 2883US10633389B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2018·Granted Apr 28, 2020·2 cites·18 claims
- 2982US2023416263A1Carm1 inhibitors and uses thereofEPIZYME INC·Filed 2022·Application pending·0 cites
- 3081US7858582B2Ophthalmic hGM-CSF preparationGENESCIENCE PHARMACEUTICALS CO LTD·Filed 2006·Granted Dec 28, 2010·24 cites·19 claims
- 3179US11155632B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 26, 2021·2 cites·11 claims
- 3277US2021308121A1Prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2021·Application pending·0 cites
- 3374US2019343826A1Tetrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Application pending·0 cites
- 3472US11834455B2Carm1 inhibitors and uses thereofEPIZYME INC·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 3572US10046313B2Mesoporous materials and processes for preparation thereofUNIV CONNECTICUT·Filed 2014·Granted Aug 14, 2018·1 cites·31 claims
- 3668US2018098987A1PRMT5 Inhibitors and Uses ThereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 3767US12173017B2Bimetallic metal-organic frameworks nanosheet based on zeolite imidazole framework/materials of institute Lavoisier topology and preparation method and application thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2024·Granted Dec 24, 2024·0 cites·4 claims
- 3867US10653693B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted May 19, 2020·1 cites·17 claims
- 3966US10576462B2Mesoporous materials and processes for preparation thereofUNIV CONNECTICUT·Filed 2014·Granted Mar 3, 2020·1 cites·28 claims
- 4066US9238622B2Crystal form I of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparing method and use thereofYOU CHAO·Filed 2010·Granted Jan 19, 2016·2 cites·13 claims
- 4165US2015284422A1Inhibitors of protein methyltransferase dot1l and methods of use thereofEPIZYME INC·Filed 2013·Application pending·0 cites
- 4264US2018298010A1Prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2018·Application pending·0 cites
- 4363US2018186798A1Prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 4461US2018162847A1Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 4561US2009143351A1Substituted azetidinonesDAIAMED·Filed 2009·Application pending·0 cites
- 4660US12344669B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 1, 2025·0 cites·14 claims
- 4760US2019100552A1Inhibitors of protein methyltransferase dot1l and methods of use thereofEPIZYME INC·Filed 2018·Application pending·0 cites
- 4859US2018237397A1Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 4955US2024190875A1Spiroindoline derivative, and preparation method and medical use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 5052US2017056409A1Carm1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lei Jin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →